Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology, 2008-09, Vol.7 (3), p.204-213
Ambulatory Impedance Cardiography in Hypertension: A Validation Study
Ist Teil von
European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology, 2008-09, Vol.7 (3), p.204-213
Ort / Verlag
London, England: SAGE Publications
Erscheinungsjahr
2008
Quelle
MEDLINE
Beschreibungen/Notizen
The management of hypertension is improved by knowledge of the hemodynamics underlying blood pressure. Impedance Cardiography (ICG) provides data on a range of hemodynamic variables that affect blood pressure. However, ICG captures only fixed descriptions of hemodynamic characteristics. Improvements in ambulatory technology have led to the development of the Ambulatory Impedance Monitor (AIM) which records hemodynamic data during the activities of daily living. The purpose of this study was to evaluate the sensitivity of the AIM to detect hemodynamic changes associated with postural shift in persons with hypertension. Using a repeated measures cross-over design, sitting and standing hemodynamic measures were taken in seventeen persons with hypertension while wearing the AIM-BpTRU system designed for standard office use and the AIM-Spacelabs system designed for ambulatory monitoring. Both AIM-blood pressure monitoring systems detected significant changes from sitting to standing posture in heart rate (p = 0.03), stroke volume (p = 0.002), left ventricular ejection time (p < 0.001), systemic vascular resistance (p = 0.03) and diastolic blood pressure (p < 0.001). Additionally, both systems generated measures of cardiac function that were positively correlated (p < 0.001) and not significantly different (p > 0.05). Our findings support previous work and demonstrate that the AIM provides valid and reliable estimates of cardiac function in persons with hypertension.